Phase I study of a novel therapeutic vaccine as perioperative treatment for patients with surgically resectable hepatocellular carcinoma: The YCP02 trial.
Nakajima M, Hazama S, Tokumitsu Y, Shindo Y, Matsui H, Matsukuma S, Nakagami Y, Tamada K, Udaka K, Sakamoto M, Saito A, Kouki Y, Uematsu T, Xu M, Iida M, Tsunedomi R, Suzuki N, Takeda S, Ioka T, Doi S, Nagano H.
Nakajima M, et al. Among authors: ioka t.
Hepatol Res. 2023 Jul;53(7):649-660. doi: 10.1111/hepr.13900. Epub 2023 Mar 30.
Hepatol Res. 2023.
PMID: 36929310